Voyageur Total Assets from 2010 to 2026
| VM Stock | CAD 0.18 0.01 5.88% |
Total Assets | First Reported 2012-05-31 | Previous Quarter 3.2 M | Current Value 3 M | Quarterly Volatility 1 M |
Check Voyageur Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Voyageur Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 757.3 K, Other Operating Expenses of 779.8 K or Total Operating Expenses of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.13. Voyageur financial statements analysis is a perfect complement when working with Voyageur Pharmaceuticals Valuation or Volatility modules.
Voyageur | Total Assets |
Latest Voyageur Pharmaceuticals' Total Assets Growth Pattern
Below is the plot of the Total Assets of Voyageur Pharmaceuticals over the last few years. Total assets refers to the total amount of Voyageur Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Voyageur Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Voyageur Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Voyageur Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.6 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Voyageur Total Assets Regression Statistics
| Arithmetic Mean | 1,456,525 | |
| Geometric Mean | 896,857 | |
| Coefficient Of Variation | 75.04 | |
| Mean Deviation | 953,281 | |
| Median | 1,275,180 | |
| Standard Deviation | 1,092,981 | |
| Sample Variance | 1.2T | |
| Range | 3M | |
| R-Value | 0.96 | |
| Mean Square Error | 88.5B | |
| R-Squared | 0.93 | |
| Slope | 208,790 | |
| Total Sum of Squares | 19.1T |
Voyageur Total Assets History
About Voyageur Pharmaceuticals Financial Statements
Voyageur Pharmaceuticals investors use historical fundamental indicators, such as Voyageur Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Voyageur Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 3 M | 3.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.